Review Article
Year: 2022 | Month: October-December | Volume: 7 | Issue: 4 | Pages: 35-43
DOI: https://doi.org/10.52403/ijshr.20221006
A Critical Review on Prescribing Pattern Monitoring of Neurological Disorders in a Tertiary Care Teaching Hospital
Puneet Chauhan1, Junaid Tantray2, Dr. Sourabh Kosey3, Anuj Sharma4, Dr. Kamlesh Chaudhary5, Rajeev Gupta6, Uttam Kumar7
1,4,6,7Nims Institute of Pharmaceutical Sciences NIMS UNIVERSITY, Rajasthan Jaipur
2(Assistant Professor) Nims Institute of Pharmaceutical Sciences NIMS UNIVERSITY
3(Associate Professor) HOD Dept. of Pharmacy Practice Nims Institute of Pharmaceutical Sciences NIMS UNIVERSITY
5MBBS, MD(Medicine), DM Neurology, Consultant Neuro Physician, Dept. of Neurology NIMS Institute of Medical Sciences & Research (NIMSHR) NIMS University Rajasthan, Jaipur, India
Corresponding Author: Puneet Chauhan
ABSTRACT
Neurological diseases have a significant impact on global health. According to the most recent estimates, the neurological disorders included in the Global Burden of Disease (GBD) Study—and Alzheimer's other dementias, Parkinson's disease, multiple sclerosis, epilepsy, and headache disorders (migraine, tension-type headache [TTH], and medication-overuse headache [MOH]—represent 3% of the global disease burden. [1] Prescription pattern monitoring studies (PPMS) are drug use studies that concentrate on prescription prescribing, dispensing, and administration. They advocate for the proper use of controlled substances and the decrease of drug addiction or misuse. Neurological problems impact around 100 million individuals worldwide. In developing nations, where the prevalence of Polypharmacy, excessive antibiotic usage, injections, "off-label" medication use, and ineffective treatments is high, irrational drug use is a widespread problem. Numerous studies have documented prescription data practices among adults in different countries. But there is still the lack of information on the prescribing practices in neurology. Drugs administered to paediatric population suffering from neurological disorders are the same as those for adults/geriatric population that were originally formulated. However, in addition to the disease profile, growth and development processes in patients suffering from neurological disorders may subject them to multiple adverse effects. . It is important to monitor the patient to ensure drug compliance and avoid relapse. People with excellent educational backgrounds were aware of the early signs and risk factors for stroke. The standard WHO prescription standards were followed by effective prescribing practises. Instead of using the recommended generic names, brand-name prescriptions of drugs raise concerns.
Keywords: Drug auditing, drug utilization pattern, pharmacoepidemiology, prescription-monitoring, rational use of drugs.